COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry.

Autor: Porta-Etessam J; Hospital Clínico San Carlos, Madrid, Spain. jporta@yahoo.com.; Universidad Complutense de Madrid, Madrid, Spain. jporta@yahoo.com.; Neurology Department. C/Profesor Martín Lagos S/N, 28049, Madrid, Spain. jporta@yahoo.com., Núñez-Gil IJ; Hospital Clínico San Carlos, Madrid, Spain., González García N; Hospital Clínico San Carlos, Madrid, Spain.; Neurology Department. C/Profesor Martín Lagos S/N, 28049, Madrid, Spain., Fernandez-Perez C; Instituto para la Mejora de la Asistencia Sanitaria, Madrid, Spain., Viana-Llamas MC; Hospital Universitario Guadalajara, Guadalajara, Spain., Eid CM; Hospital Universitario La Paz. Instituto de Investigación Hospital Universitario La Paz (IdiPAZ), Madrid, Spain., Romero R; Hospital Universitario Getafe, Madrid, Spain., Molina M; Hospital Universitario Severo Ochoa, Leganés, Spain., Uribarri A; Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Becerra-Muñoz VM; Hospital Clínico Universitario Virgen de La Victoria, Málaga, Spain., Aguado MG; Hospital Puerta de Hierro de Majadahonda, Madrid, Spain., Huang J; The Second Affiliated Hospital of Southern, University of Science and Technology Shenzhen, Shenzhen, China., Rondano E; Sant'Andrea Hospital, Vercelli, Italy., Cerrato E; San Luigi Gonzaga University Hospital, Orbassano and Rivoli Infermi Hospital, Rivoli, Turin, Italy., Alfonso E; Institute of Cardiology and Cardiovascular Surgery, Havana, Cuba., Mejía AFC; Hospital General del Norte de Guayaquil IESS Los Ceibos, Guayaquil, Ecuador., Marin F; Hospital Universitario Virgen de La Arrixaca, Murcia, Spain., Roubin SR; Hospital Universitario Álvaro Cunqueiro, Vigo, Spain., Pepe M; Azienda Ospedaliero-Universitaria Consorziale Policlinico Di Bari, Bari, Italy., Feltes G; Hospital Nuestra Señora de América, Madrid, Spain., Maté P; Hospital Universitario Infanta Sofia, San Sebastian de Los Reyes, Madrid, Spain., Cortese B; San Carlo Clinic, Milano, Italy., Buzón L; Hospital Universitario de Burgos, Burgos, Spain., Mendez JJ; Hospital de Especialidades de Las Fuerzas Armadas N1, Quito, Ecuador., Estrada V; Hospital Clínico San Carlos, Madrid, Spain.

Publikováno v: Infection [Infection] 2021 Aug; Vol. 49 (4), pp. 677-684. Date of Electronic Publication: 2021 Mar 01.

Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis.

Autor: Ruiz-Sánchez JG; Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain., Núñez-Gil IJ; Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain., Cuesta M; Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain., Rubio MA; Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain., Maroun-Eid C; Hospital Universitario La Paz, Instituto de Investigación Hospital Universitario La Paz (IdiPAZ), Madrid, Spain., Arroyo-Espliguero R; Hospital Universitario Guadalajara, Guadalajara, Spain., Romero R; Hospital Universitario Getafe, Universidad Europea de Madrid, Madrid, Spain., Becerra-Muñoz VM; Hospital Clinico Universitario Virgen de la Victoria, Málaga, Spain., Uribarri A; Hospital Clinico Universitario de Valladolid, Valladolid, Spain., Feltes G; Hospital Nuestra Señora de América, Madrid, Spain., Trabattoni D; Centro Cardiologico Monzino, IRCCS, Milan, Italy., Molina M; Hospital Universitario Severo Ochoa, Madrid, Spain., García Aguado M; Hospital Puerta de Hierro de Majadahonda, Madrid, Spain., Pepe M; Azienda ospedaliero-universitaria consorziale policlinico di Bari, Bari, Italy., Cerrato E; San Luigi Gonzaga University Hospital, Orbassano and Rivoli Infermi Hospital, Rivoli, Turin, Italy., Alfonso E; Institute of Cardiology and Cardiovascular Surgery, Havana, Cuba., Castro Mejía AF; Hospital General del norte de Guayaquil IESS Los Ceibos, Guayaquil, Ecuador., Roubin SR; University Hospital Álvaro Cunqueiro, Vigo, Spain., Buzón L; Hospital Universitario de Burgos, Burgos, Spain., Bondia E; Hospital Clínico Universitario, Incliva, Universidad de Valencia, Valencia, Spain., Marin F; Hospital de la Arreixaca, Murcia, Spain., López Pais J; Hospital Santiago Compostela, Santiago de Compostela, Spain., Abumayyaleh M; First Department of Medicine, Medical Faculty Mannheim, University Heidelberg, Mannheim, Germany, DZHK (German Center for Cardiovascular Research), Partner Site, Heidelberg-Mannheim, Mannheim, Germany., D'Ascenzo F; San Giovanni Battista Hospital, Turin, Italy., Rondano E; Sant'Andrea Hospital, Vercelli, Italy., Huang J; The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, China., Fernandez-Perez C; Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain., Macaya C; Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain., de Miguel Novoa P; Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain., Calle-Pascual AL; Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain., Estrada Perez V; Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain., Runkle I; Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

Publikováno v: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2020 Nov 30; Vol. 11, pp. 599255. Date of Electronic Publication: 2020 Nov 30 (Print Publication: 2020).

Tobacco smoke affects expression of peroxisome proliferator-activated receptor-γ in monocyte/macrophages of patients with coronary heart disease

Autor: Amoruso, A, Gunella, G, Rondano, E, Bardelli, C, Fresu, LG, Ferrero, V, Ribichini, F, Vassanelli, C, Brunelleschi, S

Tobacco smoke represents a relevant risk factor for coronary heart disease (CHD). Although peroxisome proliferator-activated receptor (PPAR)gamma activation reduces inflammation and atherosclerosis, expression of PPARgamma in cells and its modulation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5f25a496bf651b39a9f2639f632bfba4
https://europepmc.org/articles/PMC2782336/

Atrial asynchrony and function before and after electrical cardioversion for persistent atrial fibrillation†.

Autor: Dell'Era G, Rondano E, Franchi E, Marino PN

Publikováno v: European Journal of Echocardiography; Aug2010, Vol. 11 Issue 7, p577-583, 7p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.